Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Poolbeg Pharma (POLB) Share News

12345

LONDON BRIEFING: Chrysalis settles claims with Revolution Beauty

2nd Jan 2025 07:48

(Alliance News) - London's FTSE 100 is set to open the year in the green, with a series of manufacturing purchasing managers' index readings the first hurdle for equities in 2025. Read More

Poolbeg Pharma granted US patent for influenza treatment

20th Nov 2024 18:26

(Alliance News) - Poolbeg Pharma PLC on Wednesday announced its immunomodulator I patent has been granted in the US. Read More

EARNINGS AND TRADING: Man Group profit rises; Petershill AUM increases

26th Jul 2024 18:59

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

6th Jun 2024 14:52

Read More

Poolbeg Pharma celebrates full patent approval for Immunomodulator II

1st May 2024 16:39

(Alliance News) - Poolbeg Pharma PLC on Wednesday said that it has received a fully granted patent from the US Patent Office for its Immunomodulator II patent application. Read More

EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down

30th Apr 2024 16:30

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake

20th Mar 2024 16:18

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Diversified Energy offers dividend alternative

15th Feb 2024 16:02

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

TRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-up

12th Feb 2024 19:44

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Poolbeg Pharma hails POLB 001'S potential to treat CRS

17th Jan 2024 13:58

(Alliance News) - Poolbeg Pharma PLC on Wednesday noted "promising" results for POLB 001's potential in treating cancer immunotherapy-induced cytokine release syndrome. Read More

TRADING UPDATES: K3 Business says cash balances ahead of forecast

20th Dec 2023 20:00

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Poolbeg hails approval; EDX links with Thermo Fisher

21st Nov 2023 14:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Poolbeg Pharma appoints former Amryt executives to team

9th Nov 2023 16:57

Poolbeg Pharma PLC - Clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need - Appoints a number of former executives of Amryt Pharma PLC to its leadership team. Poolbeg's Chair, Cathal Friel, co-founded both Poolbeg and Amryt Pharma. Read More

Poolbeg Pharma shares up on metabolic drug collaboration agreement

17th Oct 2023 10:49

(Alliance News) - Poolbeg Pharma PLC on Tuesday said it has agreed to collaborate with an unnamed Nasdaq-listed biopharmaceutical company for the development of an optimised oral drug to treat a metabolic condition. Read More

EARNINGS AND TRADING: Kingswood cuts outlook; Poolbeg in patent joy

2nd Oct 2023 14:20

(Alliance News) - The following is a round-up of updates by London-listed companies, issued last week and not separately reported by Alliance News: Read More

TRADING UPDATES: Braemar investigation to end; Marula reports delay

22nd Sep 2023 20:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday, Thursday and Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Chill Brands unphased by regulations; Cobra inks deal

19th Sep 2023 14:42

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

EARNINGS: Frontier Developments turns to loss; Poolbeg optimistic

13th Sep 2023 14:41

(Alliance News) - The following is a round-up of earnings of London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Poolbeg Pharma makes "significant" influenza breakthrough with AI

29th Jun 2023 16:52

(Alliance News) - Poolbeg Pharma PLC on Thursday said it has made a significant breakthrough in its "world-first" influenza artificial intelligence programme with CytoReason Ltd. Read More

IN BRIEF: Poolbeg oral vaccination programme moves forward

22nd Jun 2023 13:38

Poolbeg Pharma PLC - London-based infectious disease focused biopharmaceutical company - Says oral vaccine programme is moving forward to encapsulation validation process. Expects validation to be completed in the second half of 2023. Back in November, Poolbeg's consortium EncOvac received funding of EUR2.3 million from the Irish government to improve the manufacturing, distribution and administration of its oral vaccines. Poolbeg is collaborating with University College Dublin, Trinity College Dublin and AnaBio Technologies over three years to develop an oral vaccine candidate to a phase 1 ready state. Read More

12345
FTSE 100 Latest
Value8,774.65
Change-17.15